Claude Wischik is the founder of TauRx Pharmaceuticals. TauRx Pharmaceuticals has raised $300M in total funding. Latest round: Series E. Backed by Genting.
Professor Claude Wischik is the Chairman and co-founder of TauRx Pharmaceuticals, a company developing treatments for Alzheimer's disease and behavioral variant frontotemporal dementia (bvFTD). He led TauRx to develop its portfolio to the Phase 2 clinical level and worked with Singaporean colleagues to raise significant funding for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library